Tonix Pharmaceuticals Holding Corp. SEC filings TNXP

Tonix Pharmaceuticals Holding Corp. has 1,000 filings in SEC EDGAR's recent list, going back to May 2, 2017. Its latest annual report, Form ARS, was filed on Mar 13, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 15, 2026 (results of operations, other events). The company's fiscal year ends on December 31.

Tonix Pharmaceuticals Holding Corp. SEC filings
Form Description Filed Period
8-K Current report
Results of operations, Other events
Oct 15, 2026 Oct 15, 2026
8-K Current report
Other events
Oct 2, 2026 Oct 1, 2026
8-K Current report
Other events
Sep 22, 2026 Sep 22, 2026
8-K Current report
Other events
Sep 8, 2026 Sep 8, 2026
3 Initial insider ownership Sep 8, 2026 Sep 4, 2026
4 Insider transaction Aug 31, 2026 Aug 27, 2026
4 Insider transaction Aug 24, 2026 Aug 20, 2026
8-K Current report
Officer or director change, Other events
Aug 18, 2026 Aug 18, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Aug 13, 2026 —
10-Q Quarterly report Aug 10, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 10, 2026 Aug 10, 2026
8-K Current report
Regulation FD disclosure, Other events
Aug 3, 2026 Aug 3, 2026
8-K Current report
Officer or director change
Jul 21, 2026 Jul 20, 2026
8-K Current report
Regulation FD disclosure, Other events
Jul 13, 2026 Jul 13, 2026
4 Insider transaction Jul 9, 2026 Jun 30, 2026
S-8 Employee stock plan registration Jul 1, 2026 —
8-K Current report
Regulation FD disclosure, Other events
Jun 29, 2026 Jun 29, 2026
SCHEDULE 13G Ownership over 5% (passive) Jun 15, 2026 —
4 Insider transaction Jun 15, 2026 Jun 12, 2026
4 Insider transaction Jun 9, 2026 Jun 8, 2026
4 Insider transaction Jun 9, 2026 Jun 9, 2026
8-K Current report
Regulation FD disclosure, Other events
Jun 8, 2026 Jun 8, 2026
8-K Current report
Regulation FD disclosure, Other events
May 27, 2026 May 27, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
8-K Current report
Regulation FD disclosure, Other events
May 15, 2026 May 15, 2026
SCHEDULE 13G Ownership over 5% (passive) May 15, 2026 —
4 Insider transaction May 14, 2026 May 12, 2026
4 Insider transaction May 14, 2026 May 12, 2026
4 Insider transaction May 14, 2026 May 12, 2026
4 Insider transaction May 14, 2026 May 12, 2026
4 Insider transaction May 14, 2026 May 12, 2026
4 Insider transaction May 14, 2026 May 12, 2026
4 Insider transaction May 14, 2026 May 12, 2026
4 Insider transaction May 14, 2026 May 12, 2026
8-K Current report
Results of operations
May 11, 2026 May 11, 2026
10-Q Quarterly report May 11, 2026 Mar 31, 2026
8-K Current report
Officer or director change, Shareholder vote results
May 7, 2026 May 7, 2026
8-K Current report
Regulation FD disclosure, Other events
May 6, 2026 May 6, 2026
8-K Current report
Results of operations, Other events
May 1, 2026 May 1, 2026
8-K Current report
Regulation FD disclosure, Other events
Apr 29, 2026 Apr 29, 2026
8-K Current report
Regulation FD disclosure, Other events
Apr 23, 2026 Apr 21, 2026
4 Insider transaction Apr 1, 2026 Mar 31, 2026
8-K Current report
Regulation FD disclosure, Other events
Mar 31, 2026 Mar 30, 2026
DEF 14A Proxy statement Mar 30, 2026 May 7, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
8-K Current report
Regulation FD disclosure, Other events
Mar 26, 2026 Mar 26, 2026
PRE 14A Preliminary proxy statement Mar 20, 2026 May 7, 2026
4 Insider transaction Mar 18, 2026 Mar 18, 2026
8-K Current report
Auditor change
Mar 18, 2026 Mar 16, 2026
ARS Annual report to shareholders Mar 13, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 13, 2026 Mar 12, 2026
10-K Annual report Mar 12, 2026 Dec 31, 2025
8-K Current report
Regulation FD disclosure, Other events
Mar 10, 2026 Mar 10, 2026
8-K Current report
Regulation FD disclosure, Other events
Mar 3, 2026 Mar 3, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
5 Annual insider ownership Feb 17, 2026 Dec 31, 2025
8-K Current report
Results of operations, Other events
Feb 3, 2026 Feb 3, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 30, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 21, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Dec 31, 2025 —
8-K Current report
Material agreement, Other events
Dec 29, 2025 Dec 29, 2025
424B5 Prospectus supplement Dec 29, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Dec 29, 2025 Dec 29, 2025
8-K Current report
Regulation FD disclosure, Other events
Dec 16, 2025 Dec 16, 2025
8-K Current report
Regulation FD disclosure, Other events
Dec 9, 2025 Dec 9, 2025
8-K Current report
Regulation FD disclosure, Other events
Nov 24, 2025 Nov 24, 2025
424B5 Prospectus supplement Nov 21, 2025 —
8-K Current report
Material agreement, Other events
Nov 21, 2025 Nov 21, 2025
8-K Current report
Other events
Nov 18, 2025 Nov 18, 2025
8-K Current report
Regulation FD disclosure, Other events
Nov 17, 2025 Nov 17, 2025
10-Q Quarterly report Nov 10, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 10, 2025 Nov 10, 2025
SCHEDULE 13G Ownership over 5% (passive) Oct 31, 2025 —
8-K Current report
Results of operations, Other events
Oct 27, 2025 Oct 27, 2025
8-K Current report
Regulation FD disclosure, Other events
Oct 22, 2025 Oct 22, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 17, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Oct 7, 2025 Oct 7, 2025
8-K Current report
Regulation FD disclosure, Other events
Sep 30, 2025 Sep 30, 2025
8-K Current report
Regulation FD disclosure, Other events
Sep 29, 2025 Sep 29, 2025
8-K Current report
Regulation FD disclosure, Other events
Sep 18, 2025 Sep 18, 2025
8-K Current report
Regulation FD disclosure, Other events
Sep 17, 2025 Sep 17, 2025
EFFECT Filing Sep 4, 2025 —
S-3/A Amendment to form s-3 Sep 4, 2025 —
CORRESP Letter to the SEC Sep 3, 2025 —
CORRESP Letter to the SEC Sep 3, 2025 —
CORRESP Letter to the SEC Aug 29, 2025 —
4 Insider transaction Aug 21, 2025 Aug 21, 2025
4 Insider transaction Aug 20, 2025 Aug 20, 2025
8-K Current report
Regulation FD disclosure, Other events
Aug 18, 2025 Aug 18, 2025
8-K Current report
Regulation FD disclosure, Other events
Aug 15, 2025 Aug 15, 2025
8-K Current report
Results of operations
Aug 11, 2025 Aug 11, 2025
10-Q Quarterly report Aug 11, 2025 Jun 30, 2025
8-K Current report
Results of operations, Other events
Jul 25, 2025 Jul 25, 2025
8-K Current report
Regulation FD disclosure, Other events
Jul 21, 2025 Jul 21, 2025
SCHEDULE 13G Ownership over 5% (passive) Jul 17, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Jul 16, 2025 Jul 16, 2025
8-K Current report
Regulation FD disclosure, Other events
Jul 10, 2025 Jul 10, 2025
8-K Current report
Regulation FD disclosure, Other events
Jul 9, 2025 Jul 9, 2025
8-K Current report
Regulation FD disclosure, Other events
Jul 2, 2025 Jul 2, 2025
UPLOAD Letter from the SEC Jun 16, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Jun 16, 2025 Jun 16, 2025
4 Insider transaction Jun 13, 2025 Jun 12, 2025
3 Initial insider ownership Jun 13, 2025 Jun 12, 2025
8-K Current report
Officer or director change, Other events
Jun 13, 2025 Jun 12, 2025
S-3 Shelf registration Jun 12, 2025 —
424B5 Prospectus supplement Jun 11, 2025 —
424B5 Prospectus supplement Jun 11, 2025 —
8-K Current report
Material agreement
Jun 11, 2025 Jun 11, 2025
S-8 Employee stock plan registration May 30, 2025 —
8-K Current report
Regulation FD disclosure, Other events
May 21, 2025 May 21, 2025
4 Insider transaction May 15, 2025 May 15, 2025
4 Insider transaction May 15, 2025 May 13, 2025
4 Insider transaction May 15, 2025 May 13, 2025
4 Insider transaction May 15, 2025 May 13, 2025
4 Insider transaction May 15, 2025 May 13, 2025
4 Insider transaction May 15, 2025 May 13, 2025
4 Insider transaction May 15, 2025 May 13, 2025
4 Insider transaction May 15, 2025 May 13, 2025
8-K Current report
Regulation FD disclosure, Other events
May 14, 2025 May 14, 2025
8-K Current report
Results of operations
May 12, 2025 May 12, 2025
10-Q Quarterly report May 12, 2025 Mar 31, 2025
8-K Current report
Shareholder vote results
May 8, 2025 May 8, 2025
8-K Current report
Regulation FD disclosure, Other events
Apr 29, 2025 Apr 29, 2025
8-K Current report
Results of operations, Other events
Apr 25, 2025 Apr 25, 2025
8-K Current report
Regulation FD disclosure, Other events
Apr 24, 2025 Apr 23, 2025
8-K Current report
Regulation FD disclosure, Other events
Apr 9, 2025 Apr 9, 2025
8-K Current report
Regulation FD disclosure, Other events
Apr 1, 2025 Apr 1, 2025
DEF 14A Proxy statement Mar 31, 2025 May 8, 2025
8-K Current report
Regulation FD disclosure, Other events
Mar 24, 2025 Mar 24, 2025
PRE 14A Preliminary proxy statement Mar 21, 2025 May 8, 2025
ARS Annual report to shareholders Mar 18, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 18, 2025 Mar 18, 2025
10-K Annual report Mar 18, 2025 Dec 31, 2024
8-K Current report
Regulation FD disclosure, Other events
Mar 10, 2025 Mar 10, 2025
8-K Current report
Officer or director change
Mar 4, 2025 Feb 27, 2025
8-K Current report
Regulation FD disclosure, Other events
Mar 4, 2025 Mar 3, 2025
4 Insider transaction Feb 28, 2025 Feb 5, 2025
4 Insider transaction Feb 28, 2025 Feb 5, 2025
4 Insider transaction Feb 28, 2025 Jun 10, 2024
4 Insider transaction Feb 28, 2025 Feb 5, 2025
4 Insider transaction Feb 27, 2025 Feb 5, 2025
4 Insider transaction Feb 27, 2025 Feb 5, 2025
4 Insider transaction Feb 27, 2025 Feb 5, 2025
4 Insider transaction Feb 27, 2025 Feb 5, 2025
4 Insider transaction Feb 27, 2025 Feb 25, 2025
8-K Current report
Other events
Feb 21, 2025 Feb 20, 2025
3 Initial insider ownership Feb 18, 2025 Feb 3, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
8-K Current report
Regulation FD disclosure
Feb 7, 2025 Feb 7, 2025
8-K Current report
Regulation FD disclosure, Other events
Feb 6, 2025 Feb 6, 2025
8-K Current report
Officer or director change, Regulation FD disclosure, Other events
Feb 4, 2025 Feb 3, 2025
8-K Current report
Agreement ended, Results of operations, Change to shareholder rights, Other events
Feb 3, 2025 Feb 3, 2025
8-K Current report
Regulation FD disclosure, Other events
Jan 8, 2025 Jan 8, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 3, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Dec 23, 2024 Dec 23, 2024
8-K Current report
Other events
Dec 20, 2024 Dec 20, 2024
424B5 Prospectus supplement Dec 20, 2024 —
8-K Current report
Regulation FD disclosure, Other events
Dec 17, 2024 Dec 17, 2024
S-8 Employee stock plan registration Dec 6, 2024 —
8-K/A Amended current report
Regulation FD disclosure, Other events
Dec 3, 2024 Dec 3, 2024
8-K Current report
Regulation FD disclosure, Other events
Dec 3, 2024 Dec 3, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
8-K Current report
Regulation FD disclosure, Other events
Nov 13, 2024 Nov 13, 2024
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 12, 2024 Nov 12, 2024
8-K Current report
Regulation FD disclosure, Other events
Nov 8, 2024 Nov 8, 2024
8-K Current report
Regulation FD disclosure, Other events
Nov 4, 2024 Nov 4, 2024
8-K Current report
Regulation FD disclosure, Other events
Nov 1, 2024 Nov 1, 2024
8-K Current report
Shareholder vote results
Oct 30, 2024 Oct 30, 2024
8-K Current report
Results of operations, Other events
Oct 28, 2024 Oct 28, 2024
8-K Current report
Regulation FD disclosure, Other events
Oct 17, 2024 Oct 17, 2024
SC 13G/A Amended ownership over 5% (passive) Oct 16, 2024 —
8-K Current report
Regulation FD disclosure, Other events
Oct 16, 2024 Oct 16, 2024
8-K Current report
Regulation FD disclosure, Other events
Oct 8, 2024 Oct 8, 2024
EFFECT Filing Sep 30, 2024 —
8-K Current report
Regulation FD disclosure, Other events
Sep 27, 2024 Sep 27, 2024
CORRESP Letter to the SEC Sep 26, 2024 —
UPLOAD Letter from the SEC Sep 26, 2024 —
DEF 14A Proxy statement Sep 23, 2024 Oct 30, 2024
8-K Current report
Regulation FD disclosure, Other events
Sep 23, 2024 Sep 23, 2024
S-3 Shelf registration Sep 20, 2024 —
8-K Current report
Regulation FD disclosure, Other events
Sep 19, 2024 Sep 19, 2024
8-K Current report
Regulation FD disclosure, Other events
Sep 16, 2024 Sep 16, 2024
PRE 14A Preliminary proxy statement Sep 13, 2024 Oct 30, 2024
8-K Current report
Regulation FD disclosure, Other events
Sep 10, 2024 Sep 10, 2024
8-K Current report
Regulation FD disclosure, Other events
Sep 9, 2024 Sep 6, 2024
8-K Current report
Other events
Sep 6, 2024 Sep 6, 2024
8-K Current report
Other events
Aug 30, 2024 Aug 30, 2024
424B5 Prospectus supplement Aug 30, 2024 —
8-K Current report
Regulation FD disclosure, Other events
Aug 29, 2024 Aug 29, 2024
8-K Current report
Regulation FD disclosure, Other events
Aug 26, 2024 Aug 26, 2024
8-K Current report
Regulation FD disclosure, Other events
Aug 20, 2024 Aug 20, 2024
8-K Current report
Results of operations, Other events
Aug 19, 2024 Aug 19, 2024
10-Q Quarterly report Aug 16, 2024 Jun 30, 2024

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
TNXP (Nasdaq)
Fiscal year ends
December 31
Incorporated in
NV
Headquarters
Berkeley Heights, NJ
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1430306
Former names
TAMANDARE EXPLORATIONS INC. (until Oct 17, 2011)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.